These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

483 related articles for article (PubMed ID: 12907605)

  • 1. Development and characterization of DP-153, a nontumorigenic prostatic cell line that undergoes malignant transformation by expression of dominant-negative transforming growth factor beta receptor type II.
    Song K; Cornelius SC; Danielpour D
    Cancer Res; 2003 Aug; 63(15):4358-67. PubMed ID: 12907605
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Development and characterization of nontumorigenic and tumorigenic epithelial cell lines from rat dorsal-lateral prostate.
    Danielpour D; Kadomatsu K; Anzano MA; Smith JM; Sporn MB
    Cancer Res; 1994 Jul; 54(13):3413-21. PubMed ID: 8012960
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Loss of responsiveness to transforming growth factor beta induces malignant transformation of nontumorigenic rat prostate epithelial cells.
    Tang B; de Castro K; Barnes HE; Parks WT; Stewart L; Böttinger EP; Danielpour D; Wakefield LM
    Cancer Res; 1999 Oct; 59(19):4834-42. PubMed ID: 10519393
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Generation of active TGF-beta by prostatic cell cocultures using novel basal and luminal prostatic epithelial cell lines.
    Salm SN; Koikawa Y; Ogilvie V; Tsujimura A; Coetzee S; Moscatelli D; Moore E; Lepor H; Shapiro E; Sun TT; Wilson EL
    J Cell Physiol; 2000 Jul; 184(1):70-9. PubMed ID: 10825235
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Transforming growth factor beta 1 in liver carcinogenesis: messenger RNA expression and growth effects.
    Braun L; Gruppuso P; Mikumo R; Fausto N
    Cell Growth Differ; 1990 Mar; 1(3):103-11. PubMed ID: 1964076
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Restoration of transforming growth factor beta signaling pathway in human prostate cancer cells suppresses tumorigenicity via induction of caspase-1-mediated apoptosis.
    Guo Y; Kyprianou N
    Cancer Res; 1999 Mar; 59(6):1366-71. PubMed ID: 10096572
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Blockade of transforming growth factor-beta signaling suppresses progression of androgen-independent human prostate cancer in nude mice.
    Zhang F; Lee J; Lu S; Pettaway CA; Dong Z
    Clin Cancer Res; 2005 Jun; 11(12):4512-20. PubMed ID: 15958637
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Conversion from a paracrine to an autocrine mechanism of androgen-stimulated growth during malignant transformation of prostatic epithelial cells.
    Gao J; Arnold JT; Isaacs JT
    Cancer Res; 2001 Jul; 61(13):5038-44. PubMed ID: 11431338
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Fibroblast growth factor-2 mediates transforming growth factor-beta action in prostate cancer reactive stroma.
    Yang F; Strand DW; Rowley DR
    Oncogene; 2008 Jan; 27(4):450-9. PubMed ID: 17637743
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Restoration of transforming growth factor-beta type II receptor reduces tumorigenicity in the human adrenocortical carcinoma SW-13 cell line.
    Yamamoto N; Imai J; Watanabe M; Hiroi N; Sugano S; Yoshino G
    Horm Metab Res; 2006 Mar; 38(3):159-66. PubMed ID: 16673206
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Malignant transformation in a nontumorigenic human prostatic epithelial cell line.
    Hayward SW; Wang Y; Cao M; Hom YK; Zhang B; Grossfeld GD; Sudilovsky D; Cunha GR
    Cancer Res; 2001 Nov; 61(22):8135-42. PubMed ID: 11719442
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Induction of transforming growth factor-beta autocrine activity by all-trans-retinoic acid and 1 alpha,25-dihydroxyvitamin D3 in NRP-152 rat prostatic epithelial cells.
    Danielpour D
    J Cell Physiol; 1996 Jan; 166(1):231-9. PubMed ID: 8557772
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Overexpression of transforming growth factor beta type I receptor abolishes malignant phenotype of a rat bladder carcinoma cell line.
    Okamoto M; Oyasu R
    Cell Growth Differ; 1997 Aug; 8(8):921-6. PubMed ID: 9269901
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Contextual effects of transforming growth factor beta on the tumorigenicity of human colon carcinoma cells.
    Ye SC; Foster JM; Li W; Liang J; Zborowska E; Venkateswarlu S; Gong J; Brattain MG; Willson JK
    Cancer Res; 1999 Sep; 59(18):4725-31. PubMed ID: 10493532
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Transformation of intestinal epithelial cells by chronic TGF-beta1 treatment results in downregulation of the type II TGF-beta receptor and induction of cyclooxygenase-2.
    Sheng H; Shao J; O'Mahony CA; Lamps L; Albo D; Isakson PC; Berger DH; DuBois RN; Beauchamp RD
    Oncogene; 1999 Jan; 18(4):855-67. PubMed ID: 10023661
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Synergistic inhibition of phorbol ester-induced transformation of JB6 cells by transforming growth factor-beta and retinoic acid.
    De Benedetti F; Falk L; Ruscetti FW; Colburn NH; Faltynek CR; Oppenheim JJ
    Cancer Res; 1991 Feb; 51(4):1158-64. PubMed ID: 1847657
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Altered growth regulation and loss of response to retinoic acid accompany tumorigenic transformation of prostatic cells.
    Peehl DM; Sellers RG; Arnstein P; Kung HF; Rhim JS
    Anticancer Res; 1999; 19(5B):3857-64. PubMed ID: 10628324
    [TBL] [Abstract][Full Text] [Related]  

  • 18. A novel human cancer culture model for the study of prostate cancer.
    Yasunaga Y; Nakamura K; Ko D; Srivastava S; Moul JW; Sesterhenn IA; McLeod DG; Rhim JS
    Oncogene; 2001 Nov; 20(55):8036-41. PubMed ID: 11753687
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Regulation of transforming growth factor beta receptors in H-ras oncogene-transformed rat intestinal epithelial cells.
    Zhao J; Buick RN
    Cancer Res; 1995 Dec; 55(24):6181-8. PubMed ID: 8521411
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Transforming growth factor-beta 1 signaling contributes to Caco-2 cell growth inhibition induced by 1,25(OH)(2)D(3).
    Chen A; Davis BH; Sitrin MD; Brasitus TA; Bissonnette M
    Am J Physiol Gastrointest Liver Physiol; 2002 Oct; 283(4):G864-74. PubMed ID: 12223346
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 25.